|
⚲
|
| Keyboard |
| Gallagher Neil
✚
|
|
|---|---|
| CIK # | 0001972849 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001972849] | |
| 4 | [0001972849] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gallagher Neil | |
| Foghorn Therapeutics Inc | |
| Syndax Pharmaceuticals Inc | |
| Zymeworks Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Foghorn Therapeutics Inc FHTX
Stock Options (Right to buy) · derivative
|
2025-05-01 | Grant | 50,000 | $4.16 | 208,000 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-10 | Sell | 4,618 | $15.50 | 71,579 |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-05 | Grant | 23,400 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2025-02-05 | Grant | 18,500 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
|
2025-02-05 | Grant | 110,500 | $14.65 | 1,618,825 |
|
Zymeworks Inc ZYME
Stock Option (Right to Buy) · derivative
|
2024-12-10 | Grant | 31,000 | $0.00 | |
|
Zymeworks Inc ZYME
Stock Option (Right to Buy) · derivative
|
2024-04-02 | Grant | 74,000 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2024-02-07 | Grant | 34,688 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2024-02-07 | Grant | 13,125 | $0.00 | |
|
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
|
2024-02-07 | Grant | 69,375 | $22.28 | 1,545,675 |
|
Syndax Pharmaceuticals Inc SNDX
Stock Options (Right to buy) · derivative
|
2023-04-10 | Grant | 250,000 | $19.35 | 4,837,500 |